SEARCH
FDA Warns About Johnson & Johnson COVID Vaccine and Guillain-Barré Syndrome Risk—Here's What That Means
Health Magazine
2021-07-14
Views
13
Description
Share / Embed
Download This Video
Report
Of the 100 preliminary reports of Guillain-Barré syndrome, 95 were serious.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x82owot" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:56
More Than 500,000 At-Home COVID Tests Recalled, FDA Warns of Bacteria Risk
00:55
What to Know About At-Home COVID-19 Tests After FDA Warns Against Them
01:12
This TikTok User Says He Developed Guillain-Barré Syndrome After Having COVID-19—How Can That Happen?
00:50
FDA Warns Nitrate Poppers Cause 'Serious Adverse Health Effects
00:51
FDA Panel Approves Moderna COVID-19 Booster—Here's What That Means and What Happens Next
01:18
What Is an Endemic Virus? WHO Warns COVID-19 'May Never Go Away'
01:17
Dr. Fauci Warns That These 3 Businesses Should Close in Many Places to Prevent a COVID-19
00:53
WHO Warns Against Mixing COVID Vaccines—Here's What We Know So Far
00:47
CDC Director Warns of ‘Impending Doom’ as COVID-19 Cases Increase Across the US
00:54
FDA Approves the Pfizer Vaccine, Now Called Comirnaty—Here's What FDA Approval Means
00:44
FDA Panel Recommends Johnson & Johnson Booster Shot—Here's What Happens Next
00:56
CDC Warns of 'Superbug' Fungus Outbreaks in 2 US Cities—What to Know About Candida Auris